Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

Woman Transported to Salem Hospital After ‘Medication Related’ Incident at Planned Parenthood

The available data gives strong reason to believe the incident was caused by an adverse event associated with a chemical abortion.

FDA Confirms It’s Moving Forward with New Phase of Mifepristone Safety Review

‘Every woman deserves the highest standard of medical care,’ said Carol Tobias, president of National Right to Life. ‘We encourage the agency to conduct this review with transparency, scientific integrity, and an unwavering commitment to protecting women.’

U.S. Supreme Court Issues Order Allowing Ongoing Mail-Order Abortion

The move comes after a federal appellate court issued a unanimous ruling earlier this month that – if allowed to take effect – would have blocked mail-order abortion nationwide.

23 States, Over 100 Lawmakers Call on U.S. Supreme Court to Block Mail-Order Abortion Pills

The filings come as a federal district court this month reinstated the in-person dispensing requirement for the abortion drug, thereby blocking mail-order abortion nationwide. The case has now gone before the Supreme Court.

Tagged abortion pillsattorneys generalBiden administrationchemical abortionFDAFifth Circuit Court of Appealsmail order abortionmifepristonescotusstatesUS Supreme Court